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It is clear that immune cells play many sometimes con-
flicting roles in the tumor microenvironment and it would
be extremely useful to be able to visualize the distributions
of multiple phenotyped immune cells in-situ in solid
tumors. However, obtaining phenotypic information about
the various cells that play these roles in and around the
tumor has been a challenge. Existing methods can either
deliver phenotypic information on homogenous samples
(e.g., flow cytometry) or morphologic information on sin-
gle immunomarkers (standard IHC). These limitations can
be largely overcome through a multiplexed staining, ima-
ging and analysis methodology using standard clinical
FFPE tissue sections. Although multiplex methods have
been shown to be particularly useful not much has been
presented on the validation of such methods. We present
here a validation of the method for CD3, CD8 and FOXP3
in tissue microarray containing triplex follicular lymphoma
cores from 40 subjects [24 male, 16 female, age 35 to 75
years at diagnosis, median 55 years, 2- 171 months follow-
up]. This involves a sequential multi-marker labeling for
3 antigens and a counterstain; automated multispectral
imaging to separate chromogens; and an automated analy-
sis that can quantitate the per-cell marker expression,
determine the cellular phenotype, count these cells sepa-
rately in the tumor compartment and in the stroma and
provide high-resolution images of their distributions. The
IHC for each marker was optimized in as single-stain IHC
and then those specifications used as a part of the triplex
stain. The samples were scored using an automated scor-
ing methodology and the results from the triplexed
method are compared to analyses done on singly stained
sections with excellent correlation (R greater than 0.9 in
all cases), showing that multiplexed staining methods can
replicate standard IHC methods while maintaining the
inter-distribution and visualization of the markers in a single
section.
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